Skip to content
Home
About Us
Insurance
Our Doctors
Our Services
Cardiac Investigation
Implantable Devices
Procedures
Screening packages
News & Articles
Patients & Public
Health Care Providers
Videos
Recipes
Home
About Us
Insurance
Our Doctors
Our Services
Cardiac Investigation
Implantable Devices
Procedures
Screening packages
News & Articles
Patients & Public
Health Care Providers
Videos
Recipes
Search
Book an Appointment
“IS IT TIME FOR PCSK9 INHIBITOR TO BE USED AS STANDARD OF CARE FOR CARDIAC PATIENTS? – AN ASIAN PERSPECTIVE” BY DR JEREMY CHOW
June 26, 2020
DR TAN CHONG HIOK
Prev
Previous
CARDIAC STRESS TEST VS CT CORONARY ANGIOGRAM: WHICH IS BETTER?
Next
CARDIOVASCULAR TOXICITIES OF CANCER AND ITS CONTEMPORARY TREATMENT’
Next
Blog
,
Patients & Public
Aortic Regurgitation: Do You Need Treatment Now, and What Are the Latest Valve Options?
Videos
Ever wondered how a tilt table works?
Videos
Episode 6 : What happens after your tilt table test
Videos
Episode 5 : Understanding your Tilt Table Test results
Blog
,
Patients & Public
Unexplained Fainting (Syncope) in Singapore: Causes, Red Flags, and When to See a Cardiologist
Blog
,
Patients & Public
Tilt Table Testing in Singapore: What It Is and What It Diagnoses
Book an Appointment